Literature DB >> 16575405

Transcriptional regulation by p53: one protein, many possibilities.

O Laptenko1, C Prives.   

Abstract

The p53 tumor suppressor protein is a DNA sequence-specific transcriptional regulator that, in response to various forms of cellular stress, controls the expression of numerous genes involved in cellular outcomes including among others, cell cycle arrest and cell death. Two key features of the p53 protein are required for its transcriptional activities: its ability to recognize and bind specific DNA sequences and to recruit both general and specialized transcriptional co-regulators. In fact, multiple interactions with co-activators and co-repressors as well as with the components of the general transcriptional machinery allow p53 to either promote or inhibit transcription of different target genes. This review focuses on some of the salient features of the interactions of p53 with DNA and with factors that regulate transcription. We discuss as well the complexities of the functional domains of p53 with respect to these interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575405     DOI: 10.1038/sj.cdd.4401916

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  202 in total

1.  Synthesis, characterization, and evaluation of Cd[L-proline]2, a novel histone deacetylase inhibitor that induces epigenetic modification of histone deacetylase isoforms in A549 cells.

Authors:  Anusha Chidambaram; Arunachalam Sekar; Kavya S H; Ramesh Kumar Chidambaram; Kalaiarasi Arunachalam; Senthilkumar G P; Ravikumar Vilwanathan
Journal:  Invest New Drugs       Date:  2017-08-03       Impact factor: 3.850

2.  Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers.

Authors:  Pavlina Dolezelova; Katerina Cetkovska; Karen H Vousden; Stjepan Uldrijan
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

3.  Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2010-05-15       Impact factor: 11.361

Review 4.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

Review 5.  p53 at a glance.

Authors:  Colleen A Brady; Laura D Attardi
Journal:  J Cell Sci       Date:  2010-08-01       Impact factor: 5.285

6.  A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1.

Authors:  Evangelia Loizou; Ana Banito; Geulah Livshits; Yu-Jui Ho; Richard P Koche; Francisco J Sánchez-Rivera; Allison Mayle; Chi-Chao Chen; Savvas Kinalis; Frederik O Bagger; Edward R Kastenhuber; Benjamin H Durham; Scott W Lowe
Journal:  Cancer Discov       Date:  2019-05-08       Impact factor: 39.397

7.  Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation.

Authors:  Sanjeev Das; Lakshmi Raj; Bo Zhao; Yuki Kimura; Alan Bernstein; Stuart A Aaronson; Sam W Lee
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

Review 8.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

9.  Partial p53-dependence of anisomycin-induced apoptosis in PC12 cells.

Authors:  R Schipp; J Varga; J Bátor; M Vecsernyés; Z Árvai; M Pap; József Szeberényi
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

10.  Regulation of P2X(7) gene transcription.

Authors:  Lingyin Zhou; Liping Luo; Xiaoping Qi; Xin Li; George I Gorodeski
Journal:  Purinergic Signal       Date:  2009-07-16       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.